CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node StageMarkus Eckstein, Sven Wach, Elena Epple et al.|Cancers|2020Cited by 30
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In VivoSven Wach, Achim Aigner, Johannes Giedl et al.|Molecular Therapy — Nucleic Acids|2019Cited by 30
Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant ChemotherapyHelge Täubert, Sven Wach, Markus Eckstein et al.|Cells|2021Cited by 27
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patientsMarkus Eckstein, Helge Täubert, Rudolf Jung et al.|Scientific Reports|2018Cited by 24
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer PatientsAmer Abdulrahman, Verena Lieb, Markus Eckstein et al.|Cancers|2019Cited by 11